These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2888299)

  • 21. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High frequency current catheter ablation in treatment of supraventricular and atrioventricular tachycardia].
    Hindricks G; Kottkamp H; Willems S; Chen X; Wichter T; Haverkamp W; Yli-Mäyry S; Breithardt G; Borggrefe M
    Z Kardiol; 1995; 84 Suppl 2():103-21. PubMed ID: 7571774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].
    Pott C; Dechering DG; Muszynski A; Zellerhoff S; Bittner A; Wasmer K; Mönnig G; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):228-38. PubMed ID: 21113605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.
    Malcolm AD; Garratt CJ; Camm AJ
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):139-47. PubMed ID: 8485069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
    Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
    Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of calcium antagonists for cardiac arrhythmias.
    Singh BN; Nademanee K
    Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical alternatives for supraventricular tachycardias.
    Guiraudon GM; Klein GJ; Sharma AD; Yee R
    Am J Cardiol; 1989 Dec; 64(20):92J-96J. PubMed ID: 2596418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C; Mabo P; Gras D; Leclercq C
    Eur Heart J; 1993 Nov; 14 Suppl H():67-73. PubMed ID: 7904939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supraventricular tachycardia. ECG diagnosis and anatomy.
    Obel OA; Camm AJ
    Eur Heart J; 1997 May; 18 Suppl C():C2-11. PubMed ID: 9152669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
    Lüderitz B
    Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy].
    Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A
    Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supraventricular tachycardia: diagnosis and treatment.
    Dreifus LS; Hessen SE
    Cardiology; 1990; 77(3):259-68. PubMed ID: 2272062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arrhythmias Involving the Atrioventricular Junction.
    Di Biase L; Gianni C; Bagliani G; Padeletti L
    Card Electrophysiol Clin; 2017 Sep; 9(3):435-452. PubMed ID: 28838549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of re-entrant dysrhythmias.
    Olsson SB
    Eur Heart J; 1984 Sep; 5 Suppl B():19-23. PubMed ID: 6389140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant reentrant tachycardias from concealed accessory atrioventricular bypass tract and atrioventricular nodal reentry in a patient with Williams syndrome.
    Kantharia BK; Mittleman RS
    Cardiology; 1999; 91(4):264-7. PubMed ID: 10545683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic treatment of atrioventricular tachycardias.
    Goy JJ; Fromer M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S36-40. PubMed ID: 1723116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of alterations in refractoriness and conduction in the genesis of reentrant arrhythmias. Implications for antiarrhythmic effects of class III drugs.
    Wit AL; Coromilas J
    Am J Cardiol; 1993 Nov; 72(16):3F-12F. PubMed ID: 8237828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.